Inclusion Criteria:

• Age: Between 50 and 55 years, as urinary control disorders such as urgency Urinary Incontinence (UUI) are more prevalent in this age group.
• Diagnosis: Presence of UUI only, without overlap with other types of urinary incontinence.
• Body Mass Index (BMI): Normal range (18.5-25) to minimize the effect of obesity on pelvic muscle strength and treatment outcomes.
• Delivery History: 2-4 vaginal deliveries, since the number of deliveries can affect pelvic floor muscle function.
• Informed Consent: Willingness to sign a consent form and participate in the study.

Exclusion Criteria:

• Other Types of Urinary Incontinence: Mixed urinary incontinence (MUI) or stress urinary incontinence (SUI), to avoid confounding outcomes.
• Overweight/Obesity: BMI > 25, as excess weight may affect pelvic floor muscle function and treatment response.
• Cesarean Deliveries: To avoid anatomical differences in pelvic support compared to vaginal deliveries.
• Chronic Diseases: Diabetes mellitus (DM) or hypertension (HTN), which may influence bladder function or muscle strength.
• Number of Deliveries: Fewer than 2 or more than 4 deliveries, to minimize variability in pelvic floor condition.
• Pelvic Organ Prolapse: Could affect assessment of pelvic floor muscle function and bladder performance.
• Neurological Conditions: Parkinson's disease, multiple sclerosis, spinal cord injuries, or loss of sensation in the pelvic region or lower limbs, as these affect muscular and sensory control.
• Infections or Inflammation: Urinary tract infections, bladder inflammation, or active pelvic infections, to ensure safe application of magnetic stimulation.
• History of Malignancy or Cardiac Arrhythmias: To reduce health risks during intervention.
• Presence of metallic implants or implanted electronic devices (e.g., cardiac pacemakers, implantable cardioverter-defibrillators, neurostimulators, or cochlear implants).